According to the CDC, approximately 6.2 million adults in the United States have heart failure, a number that is only expected to increase.
A GlobalData report states that the heart failure market is anticipated to grow from $3.7bn in 2018 to $22.1bn in 2028 across the eight major markets. Key drivers for the market include the increasing prevalence of chronic heart failure due to the aging global population and/or the increased prevalence of co-morbidities such as diabetes, as well as improved treatment and survival after a myocardial infarction.
